BPC 157 Banned: Key Facts on the Latest FDA Decision Industry Update: Interim 503A and 503B Bulks Lists New Revisions fda warning bpc 157 peptide products New Details 157 BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 ( compounding only, no legal prescribing) into Category 1. This means An important update for anyone following the peptide space. While these compounds are still under evaluation and not FDA approved, this shift signals growing momentum toward clinician guided peptide research. Stay informed, stay